Sort   by:  
 Page size 
UnknownPhase 1 study of inotuzumab ozogamicin combined with R-GDP for the treatment of patients with relapsed/refractory CD22+ B-cell non-Hodgkin lymphoma.
Not available
S-EPMC5614242 | biostudies-literature
UnknownAt-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods.
Not available
S-EPMC11252333 | biostudies-literature
UnknownImmediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases.
Not available
S-EPMC8298011 | biostudies-literature
UnknownEarly Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Myocardial Fibrosis: The EVOLVED Randomized Clinical Trial.
Not available
S-EPMC11519785 | biostudies-literature
UnknownCharacteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19.
Not available
S-EPMC10114094 | biostudies-literature
UnknownTrauma Association of Canada Annual Scientific Meeting, Westin Calgary Calgary, Alberta, Apr. 10–11, 2015
Not available
S-EPMC8186475 | biostudies-literature
Sort   by:  
 Page size